All Stories

  1. FLT3 inhibitors: clinical potential in acute myeloid leukemia

    Article • OncoTargets and Therapy, February 2017, Dove Medical Press

    Dr Jerome Tamburini

  2. Coactivation d’AMPK et de mTORC1

    Article • médecine/sciences, October 2015, EDP Sciences

    Dr Jerome Tamburini

  3. Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia

    Article • Science Advances, September 2015, American Association for the Advancement of Science

    Dr Jerome Tamburini

  4. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia

    Article • Cell Reports, June 2015, Elsevier

    Dr Jerome Tamburini